newsfilter
← Latest News
GlobeNewswire·

MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates

Received 3 Rare Pediatric Disease Designations (RPDD) from FDA for each of 3 potential therapies for 3 different rare inherited retinopathies including AAV-AIPL1 Agreed on pathway with MHRA for Marketing Authorization